LPS binds sequentially to CD14 and TLR4/MD2 receptor triggering production of proinflammatory mediators. The LPS-induced signaling is controlled by a plasma membrane lipid PI(4,5)P 2 and its derivatives. Here, we show that stimulation of murine peritoneal macrophages with LPS induces biphasic accumulation of PI(4,5)P 2 with peaks at 10 and 60-90 min that were still seen after silencing of TLR4 expression. In contrast, the PI(4,5)P 2 elevation was abrogated when CD14 was removed from the cell surface. To assess the contribution of CD14 and TLR4 to the LPS-induced PI(4,5)P 2 changes, we used HEK293 transfectants expressing various amounts of CD14 and TLR4. In cells with a low content of CD14 and high of TLR4, no accumulation of PI(4,5)P 2 occurred. With an increasing amount of CD14 and concomitant decrease of TLR4, 2 peaks of PI(4,5)P 2 accumulation appeared, eventually approaching those found in LPS-stimulated cells expressing CD14 alone. Mutation of the signaling domain of TLR4 let us conclude that the receptor activity can modulate PI(4,5)P 2 accumulation in cells when expressed in high amounts compared with CD14. Among the factors limiting PI(4,5)P 2 accumulation are its hydrolysis, phosphorylation, and availability of its precursor, PI(4)P. Inhibition of PLC and PI3K or overexpression of PI4K IIa that produces PI(4)P promoted PI(4,5)P 2 elevation in LPS-stimulated cells. The elevation of PI(4,5)P 2 was dispensable for TLR4 signaling yet enhanced its magnitude. Taken together, these data suggest that LPS-induced accumulation of PI(4,5)P 2 that maximizes TLR4 signaling is controlled by CD14, whereas TLR4 can fine tune the process by affecting the PI(4,5)P 2 turnover.
Introduction
TLRs recognize a variety of microbial signatures, so-called pathogen-associated molecular patterns, and trigger innate immune responses. Among the TLRs, TLR4 is activated by LPS, a component of the outer membrane of Gram-negative bacteria [1] . Activated TLR4 initiates proinflammatory cascades in which large amounts of cytokines are released, aiding the eradication of the bacteria. However, excessive host responses to LPS can lead to systemic inflammatory conditions, called sepsis, severe sepsis, and septic shock, with the mortality rate of the 2 latter reaching 30% [2, 3] . This makes detailed deciphering of the molecular mechanisms of TLR4 signaling of utmost importance.
TLR4 is a single-spanning transmembrane protein with an extracellular domain that associates constitutively with MD2 protein [4] . Typically, activation of TLR4 requires a cascade of events, starting from an interaction of LPS aggregates with LBP in the serum. LBP facilitates subsequent binding of LPS monomers to CD14, a protein anchored through a GPI linker in the outer leaflet of the plasma membrane, which is abundant in macrophages and dendritic cells. CD14 transfers the LPS to MD2 in the TLR4/MD2 complex [5, 6] . By simultaneous binding of MD2 and the TLR4 receptor from an adjacent complex, LPS mediates dimerization of the TLR4/MD2 complexes. This, in turn, facilitates recruitment of a pair of adaptor proteins, TIRAP and MyD88, to the intracellular TIR signaling domain of the receptor. MyD88 then recruits the IRAK4 and IRAK2 (or IRAK1) kinases in a sequential manner, and a so-called myddosome is assembled [7, 8] . In the TIRAP/MyD88 pair of adaptor proteins, MyD88 is considered a "signaling," whereas TIRAP a "sorting," adaptor, governing MyD88 recruitment to TLR4. Besides the TIR domain, TIRAP also binds a plasma membrane lipid, PI(4,5)P 2 , and some other lipids. In this manner, TIRAP facilitates the binding of MyD88 and myddosome assembly at the cell-surface TLR4 and is also involved in the signaling of other plasma membrane-localized TLRs [9] [10] [11] . Recently, an ability of TIRAP to bind phosphatidylinositols located in endosomal membranes is also indicated [12] . The myddosome at TLR4 triggers a signaling cascade, leading to the activation of NF-kB that controls expression of numerous proinflammatory cytokines, including TNF-a [13] . The TIRAP/MyD88-dependent signaling is followed by internalization of activated TLR4 [14, 15] . In the endosome, TLR4 recruits a second pair of adaptor proteins-TRAM and TRIF-which trigger a signaling cascade, activating IRF3/7 and leading to the expression of type I IFNs [16] . In addition, this signaling pathway contributes to a late-phase activation of NF-kB [13] .
Recent discoveries have modified our understanding of the role played by CD14 in LPS-induced signaling in macrophages. On the one hand, it has been established that at high doses of LPS, especially its more hydrophobic, "rough" chemotype, the participation of CD14 in TNF-a production can be dispensable, which suggests that TLR4 can trigger MyD88-dependent signaling without CD14 assistance [17] [18] [19] [20] . On the other hand, CD14 governs the internalization of activated TLR4 required for the TRAM/TRIF signaling of the receptor [19, 21] . The process engages Syk tyrosine kinase, PLCg2, which cleaves PI(4,5)P 2 and initiates intracellular Ca 2+ release [21, 22] , as well as the 110d isoform of PI3K, which catalyzes phosphorylation of PI(4,5)P 2 to PI(3,4,5)P 3 [11] . It is noteworthy that a growing number of data underline the pivotal role of PI(4,5)P 2 and its derivatives in TLR4 signaling. We have recently found that LPS induces biphasic accumulation of PI(4,5)P 2 in J774 macrophage-like cells. The first phase of PI(4,5)P 2 accumulation, seen as soon as at 5-10 min of LPS action, is correlated with clustering of CD14 in the plasma membrane. Moreover, CD14 expressed ectopically in HEK293 cells promoted a similar biphasic elevation of PI(4,5)P 2 during exposure of the transfectants to LPS. Based on those data, we inferred that CD14 triggers PI(4,5)P 2 generation upon binding of LPS [23] .
In this study, we reveal that LPS induces similar changes of the PI(4,5)P 2 level in primary murine macrophages. This prompted us to assess whether the LPS-induced accumulation of PI(4,5)P 2 is controlled by a cooperation of CD14 and TLR4 using HEK293 cells expressing various amounts of these 2 proteins. We found that CD14 alone determines the elevation of PI(4,5)P 2 , whereas TLR4 can modulate this elevation when expressed in high amounts compared with CD14. The accumulation of PI(4,5)P 2 in cells turned out dispensable for TLR4 signaling but enhanced its magnitude.
MATERIALS AND METHODS
Cell culture and stimulation C57BL/6 mice were purchased from the Center of Experimental Medicine (Bialystok, Poland). Male mice, 8-10 wk old, were injected intraperitoneally with 1 ml 3% thioglycolate (Difco, Lawrence, KS, USA) and 4-5 d later, were killed by inhalation of isoflurane (Baxter, Deerfield, IL, USA), followed by cervical dislocation. Inflammatory peritoneal cells were washed out with PBS; resuspended in RPMI-1640 medium with 10% FBS (Life Technologies, Warsaw, Poland), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin, and 25 mM Hepes, pH 7.4; and plated in culture-treated plates. After overnight incubation (37°C, 5% CO 2 ), cultures were washed with PBS to leave adherent macrophages for experiments. The studies were reviewed and approved by a local Animal Ethics Committee. HEK293 cells were cultured in high-glucose DMEM (Sigma-Aldrich, Poznan, Poland) with 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin and transfected, as described below.
For stimulation of primary macrophages or transfected HEK293 cells, culture medium was exchanged for 2 h and subsequently supplemented with 100 ng/ml LPS (ultrapure smooth LPS from Escherichia coli O111:B4; List Biologic Laboratories, Campbell, CA, USA) or 20 ng/ml human recombinant TNF-a (ImmunoTools, Friesoythe, Germany). In some experiments, at the end of the 2 h preincubation, the cells were exposed to 10 mg/ml rat IgG2b against CD14 (clone 4C1) or rat IgG2b (BD Biosciences, Warsaw, Poland) or 10 mM U73122 or 100 nM wortmannin (both Sigma-Aldrich) or 0.12-0.16% DMSO (30 min, 37°C); the antibodies or drugs were present during subsequent stimulation of cells with LPS. In another set of experiments, cells were pretreated with 0.1 U/ml PI-PLC (Sigma-Aldrich) for 1 h at 37°C, according to Lloyd and Kubes [24] . Subsequently, the medium was removed, and cells were washed twice with PBS (37°C) and exposed to respective medium with 10% FBS containing 100 ng/ml LPS and 0.1 U/ml PI-PLC.
TLR4 silencing
Murine macrophages were seeded in 12-well plates (0.8 3 10 6 /well) and left to adhere, as above. Before experiments, cells were washed with PBS and covered with 400 ml RPMI-1640 medium containing the other components described above. Subsequently, the wells were supplemented with 400 ml RPMI 1640 containing antibiotics and 24 ml HiPerFect (Qiagen, Hilden, Germany) and 200 nM TLR4 siRNA or scrambled siRNA (both Dharmacon, Lafayette, CO, USA); the latter mixture was incubated for 7 min before adding to cells. After 6 h, 400 ml of medium was removed, and 1.6 ml fresh RPMI-1640 medium containing 10% FBS, 2 mM L-glutamine, antibiotics, and 25 mM Hepes, pH 7.4, was added to each sample. Cells were cultured for another 18 h and used for experiments.
RT-qPCR analysis
Total RNA was extracted from 0. 
Gene reporter assay
HEK293 cells cotransfected with plasmids encoding distinct proteins of the LPS signaling cascade, along with NF-kB-or ISRE-dependent firefly luciferase and constitutive Renilla luciferase, were lysed in 50 ml of passive lysis buffer (Promega) and analyzed for reporter protein luminescence using dualluciferase assay reagent (Promega) in a Glomax 20/20 luminometer (Promega). Each variant was run in triplicates. The firefly luciferase activity was normalized against Renilla luciferase activity in the same sample to calculate the RLA, which was then expressed as a fold increase over the RLA value found in unstimulated cells.
Determination of PI(4,5)P 2 and PI(4)P levels in cells
Competitive 96-well ELISA assays were performed to estimate the amount of PI(4)P or PI(4,5)P 2 in samples (Echelon, Salt Lake City, UT, USA), according to the manufacturer's instructions, with modifications described previously [23] . Lipids extracted from 0.8 3 10 6 macrophages or 1 3 10 5 HEK293 cells were used for the assays. To calculate the amount of PI(4,5)P 2 or PI(4)P as picomoles per milligram of protein, the protein content in a corresponding number of cells was determined using the Bradford ULTRA kit (Novexin, Babraham, United Kingdom).
Immunoblotting
Cell lysates (5 mg protein/lane) were subjected to 10% SDS-PAGE. Separated proteins were transferred onto nitrocellulose and immunoblotted with rat anti-CD14 IgG or biotin-labeled goat anti-CD14 (BD Biosciences or R&D Systems, Minneapolis, MN, USA), mouse anti-FLAG IgG (Kodak, New Haven, CT, USA), mouse anti-Myc IgG (Thermo Fisher Scientific, Warsaw, Poland), rabbit anti-phospho-IkB IgG (Cell Signaling Technology, Leiden, The Netherlands), or mouse anti-b-actin IgG (BD Biosciences), followed by antirat, anti-mouse, anti-rabbit IgG, or streptavidin conjugated with peroxidase (Sigma-Aldrich or Jackson ImmunoResearch, West Grove, PA, USA).
Immunoreactive bands were detected with SuperSignal WestPico Chemiluminescent Substrate (Thermo Fisher Scientific) and analyzed densitometrically using the ImageJ program (U.S. National Institutes of Health, Bethesda, MD, USA).
Palmitoylation of PI4K IIa
HEK293 cells (5 3 10 5 /sample) were cotransfected with CD14, TLR4 WT, and PI4K IIa expression constructs, as described above, and after 22 h, were subjected to labeling with 50 mM ODYA17 (Cayman Chemical, Tallinn, Estonia) in DMEM containing 2% charcoal-stripped FBS (Thermo Fisher Scientific) and 30 mM Hepes, pH 7.4. After 4 h (37°C), cells were either left unstimulated or were stimulated with 100 ng/ml LPS, collected, and washed with ice-cold PBS by centrifugation (3 min, 400 g, 4°C). Subsequently, cells were lysed for 30 min (4°C) in 200 ml 50 mM phosphate buffer containing 0.5% NP-40, 100 mM NaCl, protease inhibitors (10 mg/ml aprotinin, leupeptin, and pepstatin each and 1 mM PMSF), phosphatase inhibitors (10 mM p-nitrophenyl phosphate, 1 mM orthovanadate, and 50 mM phenylarsine phosphate), and palmitoyltransferase inhibitors [10 mM palmostatin (Merck, Warsaw, Poland) and 0.2 mM 1-hexadecanesulfonyl fluoride (Cayman Chemical)]. Lysates were clarified by centrifugation (10 min, 16,000 g, 4°C), and supernatants were diluted with 2 volumes of the lysis buffer devoid of NP-40, supplemented with anti-c-Myc agarose affinity gel (SigmaAldrich), and incubated for 2.5 h at 4°C with end-over-end rotation. The samples were washed 3 times with ice-cold lysis buffer containing 0.05% NP-40, once with the buffer without the detergent (30 s each, 10,000 g, room temperature), pelleted, and suspended in 44 ml ice-cold PBS containing EDTA-free protease inhibitor cocktail (Roche, Warsaw, Poland) and 1 mM PMSF. For the click reaction, the mixture was supplemented with 1 mM tris(2-carboxyethyl)phosphine, 1 mM CuSO 4 , 100 mM tris(benzyltriazolylmethyl) amine, and 10 mM IRDye 800CW azide (LI-COR, Lincoln, NE, USA). The final volume of the reaction mixture was 49 ml. The reaction was carried out for 1 h at room temperature in the darkness with a gentle rotation. Subsequently, the samples were washed as after immunoprecipitation, then washed once in PBS, suspended in 22 ml SDS-sample buffer, and heated for 5 min at 95°C. Proteins were separated by 10% SDS-PAGE, transferred onto nitrocellulose (1 h, 0.4 A), and analyzed in an Odyssey CLx Imager (LI-COR) or subjected to immunoblotting with mouse anti-Myc IgG, as described above.
Data analysis
The significance of observed differences was determined by 2-way ANOVA and/or 1-way ANOVA with Tukey's post hoc test. ANOVA was performed with the aov function from the stats package in the R software environment. Significant differences are provided in figure legends. For clarity, not all of the significant differences are marked in the figures. Alternatively, Student's t test was used for the analysis when indicated.
RESULTS

LPS induces accumulation of PI(4,5)P 2 in primary macrophages, which requires CD14 involvement
Murine peritoneal macrophages were exposed to 100 ng/ml LPS, and cellular PI(4,5)P 2 level was followed for 90 min. The stimulation with LPS led to a biphasic increase of PI(4,5)P 2 amount, with the first peak at 10 min, when the PI(4,5)P 2 level rose ;1.6-fold compared with unstimulated cells. After a subsequent drop, the second PI(4,5)P 2 peak was seen at 60-90 min of LPS action (Fig. 1A) . This biphasic LPS-induced accumulation of PI(4,5)P 2 in macrophages was abolished by a pretreatment of the cells with 10 mg/ml anti-CD14 antibody, clone 4C1 (Fig. 1A) , which inhibits the binding of LPS to CD14 [26] . As the antibody could have induced CD14 but also TLR4 internalization [27] , the involvement of CD14 in the PI(4,5)P 2 elevation was verified by exposing macrophages to external PI-PLC. This enzyme cleaves the GPI anchor, thus releasing CD14 from the cell surface, as confirmed by immunoblotting of PI-PLC-treated macrophages (Fig. 1B) . In these conditions, LPS failed to induce PI(4,5)P 2 accumulation in the cells (Fig. 1A) . In contrast, the silencing of TLR4 expression with siRNA did not alter significantly the level of PI(4,5)P 2 generated in LPSstimulated macrophages (Fig. 1C ). An accumulation of PI(4,5)P 2 was still detectable in macrophages exposed to TLR4-targeting siRNA at 10 and 60 min of LPS action, despite a profound depletion of TLR4 reaching 80% at the mRNA level ( Fig. 1C and  D) . Taken together, the data point to a crucial role of CD14 and question the involvement of TLR4 in LPS-induced PI(4,5)P 2 accumulation in macrophages.
TLR4 affects the cellular level of CD14 in HEK293 transfectants
The obtained data concerning PI(4,5)P 2 dynamics in macrophages prompted us to analyze the involvement of CD14 and TLR4 in PI(4,5)P 2 elevation in more detail and also to examine the role of this phenomenon in LPS-induced signaling. For this purpose, we used HEK293 cells expressing various amounts of CD14 and TLR4, which were obtained by cotransfection with plasmids encoding CD14 and TLR4 WT/MD2 at a 1:2.5, 1:1, or 1:0.4 (w:w) ratio. This was achieved using a constant amount of a CD14-encoding plasmid (50 ng) and decreasing amounts of a TLR4 WT/MD2-encoding one (125, 50, or 20 ng). In a similar manner, we transfected HEK293 with CD14 and a mutant form of TLR4 bearing the P712H substitution. This mutation is located in the TIR domain of the receptor and abolishes its signaling activity [1, 25] (see also Fig. 4 ). As expected, the amount of TLR4 WT protein produced in HEK293 cells correlated with the amount of DNA used for cell transfection ( Fig. 2A and B) . Moreover, the level of TLR4 WT receptor produced in cells at a given amount of TLR4 DNA was very similar in cells coexpressing CD14 and in those lacking CD14 ( Fig. 2A and B) . Quite to the contrary, the production of CD14 protein in HEK293 cells was negatively affected by cotransfection of the cells with TLR4 WT/MD2. Thus, despite using a constant amount of CD14-encoding DNA for cell transfection, the level of CD14 protein varied; it was the lowest in cells producing the highest amount of TLR4 WT (1:2.5 ratio of CD14:TLR4/MD2 plasmids) and increased with decreasing amounts of TLR4 WT protein expressed in the cells ( Fig. 2A and  C) . We refer to the obtained series of transfectants as expressing CD14 at a low, medium, or high level, respectively (Fig. 2C) . Moreover, a similar effect on CD14 production was exerted by the cotransfection of cells with the mutant TLR4 P712H receptor. The mutant TLR4 was produced in cells at a level compared with TLR4 WT, and it also reduced the cellular level of CD14 to a similar extent as did the WT receptor ( Fig. 2A-C) . In cells with low expression of TLR4 WT or TLR4 P712H, the production of CD14 resembled that in cells devoid of TLR4 ( Fig. 2A and C) . On the other hand, transfection of cells with lower amounts of CD14-encoding plasmid resulted in a decrease of CD14 expression below the level found in cells bearing CD14 and TLR4 ( Fig. 2A and C) .
Accumulation of PI(4,5)P 2 correlates positively with the CD14 level in LPS-stimulated cells, whereas TLR4 fine tunes the lipid level
Having established conditions for reproducible expression of CD14 and TLR4 WT or TLR4 P712H at diverse amounts in HEK293 cells, we examined the level of PI(4,5)P 2 in those cells exposed to 100 ng/ml LPS (Fig. 3A and B) . In cells expressing the low amount of CD14 and high of TLR4 WT, no accumulation of PI(4,5)P 2 was seen at 5 or 60 min of LPS action (Fig. 3A) . The increase of the amount of CD14 with a concomitant drop of TLR4 WT led to the accumulation of PI(4,5)P 2 in LPS-stimulated cells at 5 and 60 min (Fig. 3A) .
Cotransfection of cells with CD14 and the mutant TLR4 P712H receptor allowed us to assess the role of TLR4-mediated signaling in LPS-induced PI(4,5)P 2 changes. The TLR4 P712H mutation did not impair the initial PI(4,5)P 2 elevation; in cells coexpressing the medium amount of CD14, even more PI(4,5)P 2 was detected at 5 min of LPS action (by ;18%) in the presence of TLR4 P712H than TLR4 WT ( Fig. 3B compared with Fig. 3A) , indicating that the TLR4-triggered signaling is not required for the PI(4,5)P 2 generation at the onset of LPS stimulation. At the later stage of stimulation (60 min), the PI(4,5)P 2 accumulation was affected by the presence of the mutant TLR4 P712H receptor in a complex manner, as its outcome depended on the amount of CD14 coexpressed in cells. In cells with the low amount of CD14, ;34% more of PI(4,5)P 2 accumulated after 60 min of stimulation in the presence of TLR4 P712H than TLR4 WT (Fig. 3B, black bars, compared  with Fig. 3A) . In contrast, in cells with the medium level of CD14, TLR4 P712H reduced the amounts of PI(4,5)P 2 by 26% compared with TLR4 WT, whereas at the high cellular level of CD14, the negative impact of the mutant TLR4 P712H receptor was reduced to 16% only (Fig. 3B , gray bars, compared with Fig. 3A) .
The above data indicate that the LPS-induced elevation of PI(4,5)P 2 in cells coexpressing CD14 and TLR4 WT or TLR4 P712H correlates tightly with the amount of CD14, but the TLR4 receptor can additionally modulate the magnitude of PI(4,5)P 2 accumulation. Notably, expression of TLR4 WT alone failed to produce any changes of PI(4,5)P 2 during 5-60 min of LPS action, regardless of the receptor's level in cells (Fig. 3C) . On the other hand, an analysis of PI(4,5)P 2 level in cells expressing CD14 alone confirmed the strong correlation between the amount of CD14 and the LPSinduced elevation of the lipid. In those cells, the amounts of PI(4,5)P 2 , accumulated at 5 and 60 min of LPS treatment, rose proportionally to increasing amounts of CD14 (Fig.  3D) . Even a small amount of CD14, lower than that found in cells cotransfected with TLR4, was sufficient to induce a 1.5-fold accumulation of PI(4,5)P 2 at 5 min of LPS action (Fig. 3D) .
Accumulation of PI(4,5)P 2 is dispensable for activation of NF-kB and IRF(s) by LPS
The obtained data indicate that a higher cellular level of CD14 allows a higher amount of PI(4,5)P 2 to accumulate in cells during their stimulation with LPS. To examine how this PI(4,5)P 2 elevation affects signaling of TLR4, we analyzed the activation of nuclear factors NF-kB and IRF(s), hallmarks of the MyD88-dependent and TRIF-dependent pathways triggered by TLR4, respectively [13] . For this purpose, cells were cotransfected with plasmids encoding firefly luciferase under the control of promoters containing NF-kB or ISRE transcription factor-binding sites. The NF-kB-luciferase reporter activity induced by LPS was prominent in all cells coexpressing CD14 and TLR4 WT. The induction was progressively stronger with increasing amounts of CD14, reaching 1.9-, 2.1-, and 2.5-fold in cells with the low, medium, and high levels of CD14, respectively (Fig. 4A) . TLR4 WT, expressed in the absence of CD14, drove a substantially weaker NF-kB-luciferase activation by LPS, whereas in cells expressing CD14 alone, no activation was observed (Fig.  4A) . As expected, the mutant TLR4 P712H receptor failed to support the induction of NF-kB-luciferase reporter activity by LPS (Fig. 4A) . As the luciferase reporter assay relies on NF-kB-driven production of the luciferase protein that requires several hours, we examined how variation of the cellular level of CD14, hence of PI(4,5)P 2 , affected phosphorylation of endogenous IkB, which precedes activation of the NF-kB-luciferase reporter. As seen in Fig. 4B and C, in cells with the low amount of CD14, the phosphorylation of IkB rose gradually from 60 to 90 min of LPS action. The LPS-induced IkB phosphorylation was accelerated and enhanced with increasing amounts of CD14 (Fig. 4A and B) . Only weak LPS-induced IkB phosphorylation was detected in cells expressing TLR4 WT alone and none in cells expressing CD14 only (Fig. 4B) . For comparison, stimulation of HEK293 transfectants with TNF-a induced fast and robust IkB phosphorylation (Fig. 4B) . In summary, the magnitude of NF-kB activation by LPS, as revealed by IkB phosphorylation, increased in correlation with increasing amounts of CD14 in cells, in agreement with the luciferase reporter data (see Fig. 4A ).
LPS also induced strong ISRE-dependent expression of luciferase in HEK293 cells cotransfected with CD14 and TLR4 WT (Fig. 4D) . In analogy to NF-kB activation, the ISREdependent induction of luciferase was stronger with increasing levels of CD14 in cells, reaching 5.2-, 6.6-, and 8.7-fold in cells with the low, medium, and high levels of CD14, respectively (Fig.  4D) . A profoundly weaker stimulation of the ISRE-dependent reporter gene was found in cells expressing TLR4 WT alone, whereas cells expressing TLR4 P712H together with CD14 or CD14 only did not respond to LPS stimulation at all (Fig. 4D) .
Notably, substantial activation of NF-kB and IRF(s) was detected in cells expressing the low amount of CD14 and high of TLR4 WT, in which LPS failed to induce PI(4,5)P 2 accumulation (compare Figs. 4A-D with 3A) . These data suggest that elevation of PI(4,5)P 2 in cells is not required for the MyD88-or TRIF-dependent signaling of TLR4, although it enhances its intensity.
Hydrolysis and phosphorylation of PI(4,5)P 2 counteract its accumulation in LPS-stimulated cells
In an attempt to reveal factor(s) determining the PI(4,5)P 2 accumulation in LPS-stimulated cells, we examined whether it could be affected by PI(4,5)P 2 hydrolysis and/or phosphorylation. To assess the role of PI(4,5)P 2 hydrolysis, HEK293 transfectants with the low amount of CD14 protein and high of TLR4 WT were exposed to U73122, an inhibitor of PLC. Under these conditions, stimulation of the cells with LPS induced a profound increase (2.5-fold) of the PI(4,5)P 2 level, which contrasted with the lack of PI(4,5)P 2 elevation in the absence of the drug (Fig. 5A) . Notably, U73122 treatment facilitated the elevation of PI(4,5)P 2 only at 5 min of stimulation, indicating that PI(4,5)P 2 hydrolysis accompanies its generation at the beginning of LPS action. On the other hand, inhibition of PI3K activity with wortmannin caused an elevation of PI(4,5)P 2 in cells at 60 min of stimulation, suggesting that phosphorylation of PI(4,5)P 2 counteracts its accumulation at the later stage of LPS treatment. To examine whether the LPS-induced PI(4,5)P 2 generation can be limited by the availability of its precursor, HEK293 cells were cotransfected with DNA encoding PI4K IIa, 1 of 4 kinases synthesizing PI(4)P [28, 29] . The overproduction of PI4K IIa was confirmed by immunoblotting, and it did not change substantially the amounts of TLR4 WT and CD14 coexpressed in the cells (Fig. 5B) or the basal level of PI(4,5)P 2 in unstimulated cells (Fig. 5A ). Upon stimulation with LPS, pronounced generation of PI(4)P was found in those cells, which rose 1.7-fold after 5 min and as high as 3.8-fold after 60 min compared with unstimulated cells (Fig. 5C ). This overproduction of PI(4)P greatly enhanced the LPS-induced PI(4,5)P 2 generation in HEK293 transfectants, both at 5 and 60 min (Fig. 5A) . The detected overproduction of PI(4)P and PI(4,5)P 2 was indeed a result of the PI4K IIa activity, as transfection with a mutant form of PI4K IIa lacking a palmitoylation site required for its proper cellular location and activity [30, 31] failed to affect the PI(4)P and PI(4,5)P 2 levels in LPS-stimulated cells (Fig. 5A and C) . We applied biorthogonal labeling of cells with a palmitic acid analog ODYA17, followed by a click chemistry reaction to confirm that the WT but not the mutant PI4K IIa was indeed palmitoylated in the cells. The level of palmitoylation of the kinase did not change substantially during stimulation of cells with LPS (Fig. 5D) . Notably, the stimulatory effect exerted on PI(4,5)P 2 production by PI4K IIa could not be fully nullified by the action of exogenous PI-PLC. Despite a negligible amount of CD14 remaining in PI-PLCtreated cells (Fig. 5B) , the LPS-induced production of PI(4,5)P 2 at 5 min reached the level found in cells overexpressing PI4K IIa, not treated with the exogenous enzyme (Fig. 5A ).
DISCUSSION
The plasma membrane lipid PI(4,5)P 2 and its derivatives, inositol trisphosphate and PI(3,4,5)P 3 , control several steps of the signaling cascades of LPS-activated TLR4 [10, 11, 22, 32] . In this study, we report that stimulation of murine peritoneal macrophages with LPS induces biphasic generation and accumulation of PI(4,5)P 2 with peaks at 10 and 60-90 min of LPS treatment. The accumulation of PI(4,5)P 2 was abolished when the binding of LPS to CD14 was abrogated with a function-blocking anti-CD14 antibody or when the macrophages were depleted of surface-bound CD14 by exposing cells to PI-PLC. These data are in agreement with our earlier report on biphasic generation of PI(4,5)P 2 in LPS-stimulated J774 macrophage-like cells [23] and underscore the physiologic relevance of PI(4,5)P 2 generation and accumulation induced by LPS. This prompted us to assess the contribution of both CD14 and TLR4 to the changes of the PI(4,5)P 2 level in LPS-stimulated cells and to examine the role of this PI(4,5)P 2 accumulation in the TLR4-triggered signaling.
To study the engagement of CD14 and TLR4/MD2 in PI(4,5)P 2 accumulation, we used a series of HEK293 transfectants expressing CD14 together with either WT TLR4 or its signalingdefective mutant TLR4 P712H [1, 25] and also CD14 or TLR4 WT/MD2 alone. Expression of CD14, but not TLR4 WT/MD2, was sufficient to induce the accumulation of PI(4,5)P 2 in LPSstimulated cells, and the amounts of PI(4,5)P 2 strongly correlated with the amounts of CD14 (Fig. 3D) . The CD14-mediated PI(4,5)P 2 generation did not allow NF-kB or IRF(s) activation without an involvement of TLR4. For comparison, in dendritic cells, upon binding of LPS, CD14 triggers PI(4,5)P 2 hydrolysis and an influx of Ca 2+ , leading to NFAT activation independently of TLR4 [33] . Despite those differences in the ability of CD14 to induce the downstream signaling, the data point to CD14 as an important factor controlling the PI(4,5)P 2 level in LPS-stimulated cells. Accordingly, we found that the silencing of TLR4 expression in peritoneal macrophages did not impair significantly the PI(4,5)P 2 elevation induced by LPS. On the other hand, the coexpression of TLR4 WT or TLR4 P712H with CD14 modified the magnitude of the PI(4,5)P 2 accumulation in cells. Thus, no PI(4,5)P 2 elevation was detected in cells bearing the low amount of CD14 and high of TLR4 WT. In contrast, the presence of the low amount of CD14 and high amount of mutant TLR4 P712H receptor facilitated accumulation of PI(4,5)P 2 at the later stage (60 min) of stimulation of cells (compare Fig. 3A with B, black bars). These data suggest that TLR4 WT counteracts the PI(4,5)P 2 generation in cells when its level is high compared with CD14. For the same reason, smaller amounts of CD14 were able to induce PI(4,5)P 2 accumulation when the protein was expressed alone than when CD14 was coexpressed with TLR4 WT (compare Fig. 3D with A) . The PI(4,5)P 2 generation induced by LPS is concomitant with both its hydrolysis and phosphorylation [11, 22] (Fig. 5C) . Therefore, one can assume that TLR4 increases the activity of PLC and/or PI3K, thereby augmenting PI(4,5)P 2 disappearance. The signaling-defective mutant TLR4 should be unable to affect the activity of the enzymes(s) using PI(4,5)P 2 , and as a result, PI(4,5)P 2 would accumulate in TLR4 P712H-bearing cells during their prolonged stimulation with LPS. PI3K is the more likely candidate for being the TLR4 downstream target than PLC, as inhibition of PI3K affected PI(4,5)P 2 accumulation, mainly at the later stage of stimulation (60 min) with LPS. Worth noting is that the positive effect exerted by the mutant TLR4 P712H receptor on the PI(4,5)P 2 level was revealed in cells with a low amount of CD14. It seems plausible that only in these conditions of modest LPS-induced PI(4,5)P 2 generation, the inhibition of PI(4,5)P 2 decay results in a detectable increase of its amounts.
The results obtained in cells coexpressing CD14 and the mutant TLR4 P712H receptor have revealed that the magnitude of the PI(4,5)P 2 elevation at the late phase of stimulation (60 min of LPS action) can be regulated by TLR4 in a more complex manner. The comparison of the PI(4,5)P 2 level in cells coexpressing TLR4 WT or TLR4 P712H and the medium amount of CD14 indicate that in these cells, the mutant TLR4 P712H receptor interferes with accumulation of PI(4,5)P 2 : the level of PI(4,5)P 2 found at 60 min in cells coexpressing TLR4 P712H and CD14 was substantially lower than that in cells coexpressing TLR4 WT and CD14 (compare Fig. 3A with B, gray bars). The difference was even more clear after 120 min of cell stimulation (not shown). The reason(s) for this phenomenon are unknown, but it could be explained by taking into account the trafficking of CD14 in LPS-stimulated cells. LPS induces fast endocytosis of CD14 that is followed by slow repopulation of CD14 on the cell surface requiring synthesis of the protein [34] . The LPS-induced endocytosis of CD14 is not affected by TLR4 signaling [34] , and the 2 proteins display different dynamics in intracellular compartments [35] . Nevertheless, TLR4-triggered signaling seems to affect the resynthesis of CD14, as LPSstimulated expression of CD14 was abolished in cells devoid of MyD88 and TRIF proteins [34] . It is possible that the mutant TLR4 P712H receptor impairs the replenishment of the cell surface with CD14, which is observed after prolonged exposure of cells to LPS and which could be up-regulated by TLR4 WT. Thus, the influence of TLR4 on the PI(4,5)P 2 level in LPSstimulated cells can be indirect, ensuing from the influence of TLR4 on the cell-surface level of CD14. In cells with the low level of TLR4 expression, including macrophages [36] , the modulatory effect exerted by the receptor on LPS-induced changes of the PI(4,5)P 2 level can be undetectable.
We found that one of the factors limiting PI(4,5)P 2 accumulation in LPS-stimulated cells is the availability of PI(4)P, the precursor of PI(4,5)P 2 , which is determined mainly by the activity of PI4Ks. Three of the 4 PI4Ks-IIa, IIIb, and partially IIb-are localized to the Golgi apparatus/trans-Golgi network, whereas PI4K IIIa is found at the Golgi/endoplasmic reticulum interface and at the plasma membrane [29] . The silencing of PI4K IIa in HeLa cells led to an ;50% reduction of PI(4)P and 60% reduction of PI(4,5)P 2 , indicating that the activity of this trans-Golgi network kinase affects significantly the overall level of PI(4)P and PI(4,5)P 2 in cells [37] . It has recently been estimated that in tsA-201 cells, ;30% of plasma membrane PI(4,5)P 2 is derived from the Golgi PI(4)P pool [38] . By taking into account the plasma membrane localization of PI(4,5)P 2 , the mechanism of the coupling between PI(4)P and PI(4,5)P 2 synthesis is drawing great interest [39] [40] [41] . Further studies are required to establish whether PI4K(s), other than PI4K IIa, contribute to the cascade leading from CD14 to PI(4,5)P 2 generation in LPS-stimulated cells. Once formed, PI(4)P is phosphorylated to PI(4,5)P 2 by PIP5-kinases Ia and Ig, and ADP-ribosylation factor 6 is an upstream regulator of their activity [10, 23, 32, 42] .
The molecular mechanism leading from the interaction of LPS and CD14 on the cell surface to PI(4,5)P 2 generation in the inner leaflet of the plasma membrane remains unknown. We have previously suggested that as a result of the involvement of plasma membrane rafts in CD14/TLR4 signaling [43] [44] [45] [46] [47] , the onset of PI(4,5)P 2 generation can be controlled by the coalescence of CD14-bearing rafts. In analogy, raft coalescence is known to trigger signal transduction by several immune receptors [48] . Our current data show, however, that despite the depletion of the plasma membrane CD14 with exogenous PI-PLC, LPS can still induce accumulation of PI(4,5)P 2 in cells, provided PI4K IIa is overexpressed. A contribution of residual CD14 to this phenomenon or an unusual TLR4 behavior, as revealed in distinct conditions (see TLR4 crosslinking in Płóciennikowska et al. [23] ), cannot be ruled out; however, recent studies pointing to an LBP-plasma membrane interaction [49] suggest another explanation. In line with those findings, LBP intercalates into the plasma membrane at the border between raft and nonraft domains and binds LPS there [49] . Therefore, these interactions could trigger raft reorganization sufficient to induce PI(4,5)P 2 generation that is likely to be promoted when an excess of its precursor is available in cells.
In these studies, we used HEK293 transfectants bearing CD14 and TLR4 WT to examine the role of the accumulation of PI(4,5)P 2 in TLR4-triggered signaling. In this model system, we observed that accumulation of the lipid correlated with progressive activation of NF-kB and IRF(s) (Fig. 4) , which reflected the MyD88-and TRIF-dependent signaling pathways of TLR4, respectively [13] . However, we also detected significant activation of NF-kB and IRF(s) in cells expressing high amounts of TLR4 WT and low of CD14, in which no PI(4,5)P 2 accumulation was induced by LPS. These results combined suggest that accumulation of PI(4,5)P 2 in cells is not required for TLR4 signaling but increases its magnitude. Accordingly, it was found earlier that silencing of genes encoding PIP5-kinase Ia and/or Ig reduced but not abolished NF-kB activation and TNF-a and RANTES production in J774 cells and in microglia. Concomitantly, silencing of those 2 PIP5-kinases fully prevented LPS-induced accumulation of PI(4,5)P 2 in J774 cells [23, 32] . By taking into account that PI(4,5)P 2 is a plasma membrane target of TIRAP, an adaptor protein involved in myddosome assembly, one can assume that binding of TIRAP to PI(4,5)P 2 that pre-exists in the plasma membrane in unstimulated cells allows myddosomes to be formed at low abundance and to trigger the MyD88-dependent signaling of TLR4. In fact, TIRAP was found at the plasma membrane in unstimulated bone marrow-derived macrophages, and a 20 min exposure of these cells to LPS led to dissociation of TIRAP from the membrane and its following proteasomal degradation [11] . On the other hand, our current studies reveal that the LPS-induced PI(4,5)P 2 generation is concomitant with its hydrolysis and phosphorylation. Such PI(4,5)P 2 turnover could allow the downstream proinflammatory signaling to be triggered, even when the balance between the
